Library of 5,6-(het)Bisarylated imidazo[1,2-b][1,2,4,5]tetrazines
Scheme 3. Preparation of Compound 27
Journal of Combinatorial Chemistry, 2010 Vol. 12, No. 4 607
Scheme 4. Arylation of Compound 27
To complete our investigations, the arylation of the C-6
and C-7 unsubstituted imidazotetrazine 27 was tested. This
compound was synthesized through the reaction of 1 with
chloroacetaldehyde using acidic conditions (Scheme 3).13
Unfortunately, the intermediate 25 was isolated in only 13%
yield. The major compound of this reaction appeared to be
tetrazine 26 (80%), which results from the hemiacetal
formation by the amino group instead of the commonly
accepted nucleophilic substitution of the chlorine atom (N-2
or N-4 of the tetrazine). All attempts to avoid this side-
reaction failed in our hands (basic or acidic media).
Nevertheless, in the presence of EtONa, the displacement
of the 3,5-dimethylpyrazole of 25 spontaneously occurred,
and 27 was isolated in 52% yield.
When 27 was irradiated with 1-bromo-4-methoxybenzene
using the described conditions, only the product of C-6
arylation 28 was isolated in 88% yield. No trace of 3, which
would result from the C-7 arylation, was observed, showing
the complete regioselectivity of this very interesting C-6
arylation (Scheme 4).
References and Notes
(1) (a) Elhakmaoui, A.; Gueiffier, A.; Milhavet, J. C.; Blache,
Y.; Chapat, J. P.; Chavignon, O.; Teulade, J. C.; Snoeck, R.;
Andrei, G.; De Clercq, E. Bioorg. Med. Chem. Lett. 1994, 4,
1937–1940. (b) Gueiffier, A.; Lhassani, M.; Elhakmoui, A.;
Snoeck, R.; Andrei, G.; Chavignion, O.; Teulade, J. C.; Kerbal,
A.; Essassi, M.; Debouzy, J. C.; Witurowo, J. P.; Blache, Y.;
Balzarini, J.; De Clercq, E.; Chapat, J. P. J. Med. Chem. 1996,
39, 2856–2859. (c) Gudmundsson, K. S.; Drach, J. C.;
Townsend, L. B. J. Org. Chem. 1997, 62, 3453–3459. (d) Pan,
S.; Wang, G.; Shinazi, R. F.; Zhao, K. Tetrahedron Lett. 1998,
39, 8191–8194. (e) Lhassani, M.; Chavignon, O.; Chezal,
J. M.; Teulade, J. C.; Chapat, J. P.; Snoeck, R.; Andrei, G.;
Balzarini, J.; De Clercq, E.; Gueiffier, A. Eur. J. Med. Chem.
1999, 34, 271–274. (f) Hamdouchi, C.; de Blas, J.; del Prado,
M.; Gruber, J.; Heinz, B. A.; Vance, L. J. Med. Chem. 1999,
42, 50–59. (g) Gudmundsson, K. S.; Williams, J. D.; Drach,
J. C.; Townsend, L. B. J. Med. Chem. 2003, 46, 1449–1455.
(2) (a) Kaminsky, J. J.; Puchalski, C.; Solomon, D. M.; Rizvi,
R. K.; Conn, D. J.; Elliot, A. J.; Lovey, R. G.; Guzik, H.;
Chui, P. J. S.; Long, J. F.; McPhail, A. T. J. Med. Chem.
1989, 32, 1686–1700. (b) Kaminsky, J. J.; Doweyko, A. M.
J. Med. Chem. 1997, 40, 427–436.
(3) (a) Rewankar, G. R.; Matthews, J. R.; Robins, R. K. J. Med.
Chem. 1975, 18, 1253–1255. (b) Rival, Y.; Grassy, G.;
Michael, G. Chem. Pharm. Bull. 1992, 40, 1170–1176.
(4) (a) Beswick, P. J.; Campbell, I. B.; Naylor, A. Int. Patent WO
9,631,509, 1996;Beswick, P. J.; Campbell, I. B.; Naylor, A.
Chem. Abstr. 1997, 126, 8117j. (b) Abiegnente, E. Actual.
Chim. Ther. 1991, 18, 1253–1257.
(5) Franke, H.; Geisler, J.; Hartfiel, U.; Franke, W.; Dorfmeister,
G.; Ganzer, M.; Johahann, G.; Rees, R. Patent DE 4,120,108,
1991; Franke, H.; Geisler, J.; Hartfiel, U.; Franke, W.;
Dorfmeister, G.; Ganzer, M.; Johahann, G.; Rees, R. Chem.
Abstr. 1992, 18, 213075v.
In conclusion, we have shown in this article that C-6
functionalized imidazo[1,2-b][1,2,4,5]tetrazines could be
efficiently synthesized using our regioselective palladium-
catalyzed arylation. Good to excellent yields were obtained
with a wide range of bromobenzene derivatives, with no
noticeable effect of the electronic nature of their substituents.
This new methodology should be suitable for the design of
more complex heterocyclic structures, such as bioactive
derivatives containing an imidazo[1,2-b][1,2,4,5]tetrazine
core.
(6) Byth, K. F.; Culshaw, J. D.; Green, S.; Oakes, S.; Thomas,
Acknowledgment. The authors thank the Ligue Contre
le Cancer Re´gion Grand Ouest, le Cance´ropoˆle Grand Ouest
and the MESR for financial support.
A. P. Bioorg. Med. Chem. Lett. 2004, 14, 2245–2248.
(7) (a) Neilson, D. G.; Watson, K. M.; Weakley, T. J. R.
J. Chem. Soc., Perkin Trans. 1 1979, 333–336. (b) Hunter,
D.; Neilson, D. G.; Weakley, T. J, R. J. Chem. Soc., Perkin
Trans. 1 1982, 1165–1170. (c) Hunter, D.; Neilson, D. G.
J. Chem. Soc., Perkin Trans. 1 1985, 1081–1086. (d) Hunter,
D.; Neilson, D. G. J. Chem. Soc., Perkin Trans. 1 1988, 1439–
1445.
Supporting Information Available. Experimental pro-
cedures, spectral data of compounds 1-28. This material
acs.org.